Viewing Study NCT04643002


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-03-09 @ 7:26 AM
Study NCT ID: NCT04643002
Status: RECRUITING
Last Update Posted: 2025-08-11
First Post: 2020-10-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module